Keyphrases
Low-dose Methotrexate
100%
Arterial Inflammation
100%
FDG PET-CT
33%
Infected Individual
33%
Ancillary
33%
Taking Part
33%
Randomized Placebo-controlled Trial
33%
Anti-inflammatory Therapy
33%
Positron Emission Tomography-computed Tomography (PET-CT)
33%
HIV-associated
33%
Inflammation
33%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Methotrexate
100%
Inflammation
100%
Anti-Inflammatory Drug
33%
Placebo
33%
Polyethylene Terephthalate
33%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Low Drug Dose
100%
Methotrexate
100%
Placebo
33%
Anti-Inflammatory Drug
33%
Positron Emission Tomography-Computed Tomography
33%